Drugs / MVA mBN85B
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00891007 | Jun 2009 → Jul 2010 | measles | Bavarian Nordic | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA mBN85B | “Two groups will receive two subcutaneous (s.c.) immunizations 4 weeks (28±3 days) apart of either either 1 x 10E7 TCID50 (Group A) or 1 x 10E8 TCID50 (Group B) MVA mBN85B.” NCT00891007 ↗ |
| Modality | Vaccine | “measles vaccine MVA mBN85B” NCT00891007 ↗ |
| Route | Subcutaneous | “two subcutaneous (s.c.) immunizations” NCT00891007 ↗ |